These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15576629

  • 1. Constitutive expression of peroxisome proliferator-activated receptor alpha-regulated genes in dwarf mice.
    Stauber AJ, Brown-Borg H, Liu J, Waalkes MP, Laughter A, Staben RA, Coley JC, Swanson C, Voss KA, Kopchick JJ, Corton JC.
    Mol Pharmacol; 2005 Mar; 67(3):681-94. PubMed ID: 15576629
    [Abstract] [Full Text] [Related]

  • 2. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
    Laughter AR, Dunn CS, Swanson CL, Howroyd P, Cattley RC, Corton JC.
    Toxicology; 2004 Oct 15; 203(1-3):83-98. PubMed ID: 15363585
    [Abstract] [Full Text] [Related]

  • 3. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES, Tian L, Wood PA.
    Mol Genet Metab; 2005 Jan 15; 84(1):39-47. PubMed ID: 15639194
    [Abstract] [Full Text] [Related]

  • 4. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
    Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM.
    J Pharmacol Exp Ther; 2006 Feb 15; 316(2):797-804. PubMed ID: 16260581
    [Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
    Xiao S, Anderson SP, Swanson C, Bahnemann R, Voss KA, Stauber AJ, Corton JC.
    Toxicol Sci; 2006 Aug 15; 92(2):368-77. PubMed ID: 16687391
    [Abstract] [Full Text] [Related]

  • 6. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A, Lindén D, Améen C, Bergström G, Oscarsson J.
    Growth Horm IGF Res; 2007 Apr 15; 17(2):154-64. PubMed ID: 17307376
    [Abstract] [Full Text] [Related]

  • 7. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna RA, Gustafsson JA, Corton JC.
    Mol Pharmacol; 2004 Dec 15; 66(6):1440-52. PubMed ID: 15371561
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
    Tien ES, Gray JP, Peters JM, Vanden Heuvel JP.
    Cancer Res; 2003 Sep 15; 63(18):5767-80. PubMed ID: 14522898
    [Abstract] [Full Text] [Related]

  • 9. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A, Viguerie N, Tiraby C, Annicotte JS, Mairal A, Klimcakova E, Lepin E, Delmar P, Dejean S, Tavernier G, Lefort C, Hidalgo J, Pineau T, Fajas L, Clément K, Langin D.
    Diabetes; 2007 Oct 15; 56(10):2467-75. PubMed ID: 17646210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
    Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S.
    Mol Pharmacol; 2010 Jul 15; 78(1):135-41. PubMed ID: 20400680
    [Abstract] [Full Text] [Related]

  • 12. Differential gene expression profiling of the molar tooth germ in peroxisome proliferator-activated receptor-alpha (PPAR-alpha) knockout mouse and in wild-type mouse: molar tooth phenotype of PPAR-alpha knockout mouse.
    Sehic A, Khuu C, Risnes S, Osmundsen H.
    Eur J Oral Sci; 2009 Apr 15; 117(2):93-104. PubMed ID: 19320717
    [Abstract] [Full Text] [Related]

  • 13. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S, Viswakarma N, Batra SK, Sambasiva Rao M, Reddy JK.
    Biochimie; 2004 Nov 15; 86(11):743-61. PubMed ID: 15589683
    [Abstract] [Full Text] [Related]

  • 14. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
    Rosen MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair ET, Lau C.
    Toxicol Pathol; 2008 Jun 15; 36(4):592-607. PubMed ID: 18467677
    [Abstract] [Full Text] [Related]

  • 15. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
    Finck BN, Bernal-Mizrachi C, Han DH, Coleman T, Sambandam N, LaRiviere LL, Holloszy JO, Semenkovich CF, Kelly DP.
    Cell Metab; 2005 Feb 15; 1(2):133-44. PubMed ID: 16054054
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
    Kawabe K, Saegusa H, Seto K, Urabe H, Motojima K.
    Int J Biochem Cell Biol; 2005 Jul 15; 37(7):1534-46. PubMed ID: 15833283
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
    Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Hara A, Hu R, Li G, Li Y, Nakamura K, Gonzalez FJ, Aoyama T.
    Biochem Pharmacol; 2008 Jul 01; 76(1):108-19. PubMed ID: 18486101
    [Abstract] [Full Text] [Related]

  • 18. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
    Rosen MB, Lee JS, Ren H, Vallanat B, Liu J, Waalkes MP, Abbott BD, Lau C, Corton JC.
    Toxicol Sci; 2008 May 01; 103(1):46-56. PubMed ID: 18281256
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL, Hebbachi A, Hauton D, Brown AM, Wiggins D, Patel DD, Gibbons GF.
    Biochem J; 2005 Jul 15; 389(Pt 2):413-21. PubMed ID: 15777286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.